* First and only vaccine approved in the U.S. for repeat vaccination 8 years or more after the first vaccination to help protect against tetanus, diphtheria and pertussis, offering flexibility for health care providers to help manage their immunization schedules(2)
* Approval based on clinical study of more than 1,300 adults demonstrating a second dose of Adacel vaccine is safe and effective when administered 8-12 years after a previous dose(1)
PR Newswire
BRIDGEWATER, N.J., Jan. 14, 2019
